Annual Cash & Cash Equivalents
$931.25M$297.12M+46.85%
Summary
- Current Value
- As of today, MDGL annual cash & cash equivalents is $931.25M, up +46.85% on
- Historical Performance
- MDGL annual cash & cash equivalents is up +244.47% over the past 3 years, and up +112.11% over the past 5 years
- All-Time High Comparison
- MDGL annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- MDGL annual cash & cash equivalents is +159.56% above its 3-year low of $358.77M reached on an earlier date
- Sector Comparison
- MDGL annual cash & cash equivalents is higher than 93.04% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $931.25M | +46.9% | +244.5% | +112.1% | +2009.0% | |
| Quarterly Cash & Cash Equivalents | $1.11B | +11.1% | +627.7% | +231.8% | +1959.7% | |
| Price | $498.44 | +81.6% | +66.2% | +357.1% | +112.5% | |
| Annual Current Assets | $1.03B | +62.1% | +280.2% | +134.7% | +2217.3% | |
| Annual Total Liabilities | $287.86M | +22.4% | +272.8% | +1029.3% | +1099.5% | |
| Annual Working Capital | $863.65M | +66.5% | +343.3% | +108.1% | +2972.9% | |
| Annual Net Income | -$465.89M | -24.7% | -92.6% | -455.0% | -689.1% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $931.25M | at high | |
| 5Y | $931.25M | at high | |
| All | $931.25M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $358.77M | N/A | +159.6% |
| 5Y | $270.35M | +244.5% | |
| All | $306.20K | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of MDGL?
As of today, MDGL annual cash & cash equivalents is $931.25M
What is 1-year change in MDGL annual cash & cash equivalents?
MDGL annual cash & cash equivalents is up +46.85% year-over-year
What is 3-year change in MDGL annual cash & cash equivalents?
MDGL annual cash & cash equivalents is up +244.47% over the past 3 years
How far is MDGL annual cash & cash equivalents from its all-time high?
MDGL annual cash & cash equivalents is currently at its all-time high
How does MDGL annual cash & cash equivalents rank versus sector peers?
MDGL annual cash & cash equivalents is higher than 93.04% of companies in Healthcare sector
When is MDGL next annual earnings release?
The next annual earnings release for MDGL is on
Quarterly Cash & Cash Equivalents
$1.11B$312.73M+38.99%
Summary
- Current Value
- As of today, MDGL quarterly cash & cash equivalents is $1.11B, up +38.99% on
- Historical Performance
- MDGL quarterly cash & cash equivalents is up +11.07% year-over-year, and up +627.68% over the past 3 years
- All-Time High Comparison
- MDGL quarterly cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- MDGL quarterly cash & cash equivalents is +379.77% above its 3-year low of $232.35M reached on
- Sector Comparison
- MDGL quarterly cash & cash equivalents is higher than 93.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.11B | +39.0% | +11.1% | +627.7% | +231.8% | |
| Annual Cash & Cash Equivalents | $931.25M | – | +46.9% | +244.5% | +112.1% | |
| Price | $498.44 | +15.0% | +81.6% | +66.2% | +357.1% | |
| Quarterly Current Assets | $1.35B | +34.2% | +26.6% | +757.1% | +298.9% | |
| Quarterly Total Liabilities | $736.73M | +130.7% | +148.8% | +397.9% | +1376.0% | |
| Quarterly Working Capital | $955.27M | +18.4% | +7.8% | +1541.6% | +231.4% | |
| Quarterly Net Income | -$114.19M | -170.1% | -6.8% | -40.6% | -97.0% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | at high | |
| 3Y | $1.11B | at high | |
| 5Y | $1.11B | at high | |
| All | $1.11B | at high |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $802.02M | +39.0% | |
| 3Y | $232.35M | +379.8% | |
| 5Y | $153.19M | +627.7% | |
| All | $306.20K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of MDGL?
As of today, MDGL quarterly cash & cash equivalents is $1.11B
What is MDGL quarterly cash & cash equivalents most recent change?
MDGL quarterly cash & cash equivalents was up +38.99% on September 30, 2025
What is 1-year change in MDGL quarterly cash & cash equivalents?
MDGL quarterly cash & cash equivalents is up +11.07% year-over-year
How far is MDGL quarterly cash & cash equivalents from its all-time high?
MDGL quarterly cash & cash equivalents is currently at its all-time high
How does MDGL quarterly cash & cash equivalents rank versus sector peers?
MDGL quarterly cash & cash equivalents is higher than 93.60% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl